Click for best price
Women?s Health Drugs Market Size, Share 2023
Women's health is a science aimed at maintaining and promoting women's health. It takes groups as its service and research objects, focuses on prevention, and closely integrates with clinical practice. The level of women?s health care in a country is closely linked to the political, economic and social status of women in that country. Over the past 50 years, my country?s women?s health undertakings have made great progress, but there are still many problems with the improvement of women?s health and women?s physical and mental health across the country, and further efforts are needed.?
This report aims to provide a comprehensive presentation of the global market for Women?s Health Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women?s Health Drugs. This report contains market size and forecasts of Women?s Health Drugs in global, including the following market information:
Global Women?s Health Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Women?s Health Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
EVISTA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Women?s Health Drugs include Bayer AG, Allergan, Merck & Co, Pfizer Inc, Amgen, Agile Therapeutics Inc, Ferring Pharmaceuticals, Mylan N.V. and Lupin (India), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Women?s Health Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Women?s Health Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Women?s Health Drugs Market Segment Percentages, by Type, 2022 (%)
EVISTA
XGEVA
Prolia
Mirena
Zometa
Reclast/Aclasta
Minastrin 24 Fe
Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Global Women?s Health Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Women?s Health Drugs Market Segment Percentages, by Application, 2022 (%)
Hormonal Infertility
Postmenopausal Osteoporosis
Endometriosis
Contraceptives
Menopause
Polycystic Ovary Syndrome
Other Applications
Global Women?s Health Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Women?s Health Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Women?s Health Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Women?s Health Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Allergan
Merck & Co
Pfizer Inc
Amgen
Agile Therapeutics Inc
Ferring Pharmaceuticals
Mylan N.V.
Lupin (India)
Eli Lilly And Company
Novartis AG
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Women?s Health Drugs, market overview.
Chapter 2: Global Women?s Health Drugs market size in revenue.
Chapter 3: Detailed analysis of Women?s Health Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Women?s Health Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Women?s Health Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Women?s Health Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Women?s Health Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Women?s Health Drugs Overall Market Size
2.1 Global Women?s Health Drugs Market Size: 2022 VS 2030
2.2 Global Women?s Health Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Women?s Health Drugs Players in Global Market
3.2 Top Global Women?s Health Drugs Companies Ranked by Revenue
3.3 Global Women?s Health Drugs Revenue by Companies
3.4 Top 3 and Top 5 Women?s Health Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Women?s Health Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women?s Health Drugs Players in Global Market
3.6.1 List of Global Tier 1 Women?s Health Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Women?s Health Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Women?s Health Drugs Market Size Markets, 2022 & 2030
4.1.2 EVISTA
4.1.3 XGEVA
4.1.4 Prolia
4.1.5 Mirena
4.1.6 Zometa
4.1.7 Reclast/Aclasta
4.1.8 Minastrin 24 Fe
4.1.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
4.2 By Type - Global Women?s Health Drugs Revenue & Forecasts
4.2.1 By Type - Global Women?s Health Drugs Revenue, 2018-2023
4.2.2 By Type - Global Women?s Health Drugs Revenue, 2024-2030
4.2.3 By Type - Global Women?s Health Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Women?s Health Drugs Market Size, 2022 & 2030
5.1.2 Hormonal Infertility
5.1.3 Postmenopausal Osteoporosis
5.1.4 Endometriosis
5.1.5 Contraceptives
5.1.6 Menopause
5.1.7 Polycystic Ovary Syndrome
5.1.8 Other Applications
5.2 By Application - Global Women?s Health Drugs Revenue & Forecasts
5.2.1 By Application - Global Women?s Health Drugs Revenue, 2018-2023
5.2.2 By Application - Global Women?s Health Drugs Revenue, 2024-2030
5.2.3 By Application - Global Women?s Health Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Women?s Health Drugs Market Size, 2022 & 2030
6.2 By Region - Global Women?s Health Drugs Revenue & Forecasts
6.2.1 By Region - Global Women?s Health Drugs Revenue, 2018-2023
6.2.2 By Region - Global Women?s Health Drugs Revenue, 2024-2030
6.2.3 By Region - Global Women?s Health Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Women?s Health Drugs Revenue, 2018-2030
6.3.2 US Women?s Health Drugs Market Size, 2018-2030
6.3.3 Canada Women?s Health Drugs Market Size, 2018-2030
6.3.4 Mexico Women?s Health Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Women?s Health Drugs Revenue, 2018-2030
6.4.2 Germany Women?s Health Drugs Market Size, 2018-2030
6.4.3 France Women?s Health Drugs Market Size, 2018-2030
6.4.4 U.K. Women?s Health Drugs Market Size, 2018-2030
6.4.5 Italy Women?s Health Drugs Market Size, 2018-2030
6.4.6 Russia Women?s Health Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Women?s Health Drugs Market Size, 2018-2030
6.4.8 Benelux Women?s Health Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Women?s Health Drugs Revenue, 2018-2030
6.5.2 China Women?s Health Drugs Market Size, 2018-2030
6.5.3 Japan Women?s Health Drugs Market Size, 2018-2030
6.5.4 South Korea Women?s Health Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Women?s Health Drugs Market Size, 2018-2030
6.5.6 India Women?s Health Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Women?s Health Drugs Revenue, 2018-2030
6.6.2 Brazil Women?s Health Drugs Market Size, 2018-2030
6.6.3 Argentina Women?s Health Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Women?s Health Drugs Revenue, 2018-2030
6.7.2 Turkey Women?s Health Drugs Market Size, 2018-2030
6.7.3 Israel Women?s Health Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Women?s Health Drugs Market Size, 2018-2030
6.7.5 UAE Women?s Health Drugs Market Size, 2018-2030
7 Women?s Health Drugs Companies Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Women?s Health Drugs Major Product Offerings
7.1.4 Bayer AG Women?s Health Drugs Revenue in Global Market (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Women?s Health Drugs Major Product Offerings
7.2.4 Allergan Women?s Health Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Women?s Health Drugs Major Product Offerings
7.3.4 Merck & Co Women?s Health Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer Inc
7.4.1 Pfizer Inc Company Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Women?s Health Drugs Major Product Offerings
7.4.4 Pfizer Inc Women?s Health Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Women?s Health Drugs Major Product Offerings
7.5.4 Amgen Women?s Health Drugs Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Agile Therapeutics Inc
7.6.1 Agile Therapeutics Inc Company Summary
7.6.2 Agile Therapeutics Inc Business Overview
7.6.3 Agile Therapeutics Inc Women?s Health Drugs Major Product Offerings
7.6.4 Agile Therapeutics Inc Women?s Health Drugs Revenue in Global Market (2018-2023)
7.6.5 Agile Therapeutics Inc Key News & Latest Developments
7.7 Ferring Pharmaceuticals
7.7.1 Ferring Pharmaceuticals Company Summary
7.7.2 Ferring Pharmaceuticals Business Overview
7.7.3 Ferring Pharmaceuticals Women?s Health Drugs Major Product Offerings
7.7.4 Ferring Pharmaceuticals Women?s Health Drugs Revenue in Global Market (2018-2023)
7.7.5 Ferring Pharmaceuticals Key News & Latest Developments
7.8 Mylan N.V.
7.8.1 Mylan N.V. Company Summary
7.8.2 Mylan N.V. Business Overview
7.8.3 Mylan N.V. Women?s Health Drugs Major Product Offerings
7.8.4 Mylan N.V. Women?s Health Drugs Revenue in Global Market (2018-2023)
7.8.5 Mylan N.V. Key News & Latest Developments
7.9 Lupin (India)
7.9.1 Lupin (India) Company Summary
7.9.2 Lupin (India) Business Overview
7.9.3 Lupin (India) Women?s Health Drugs Major Product Offerings
7.9.4 Lupin (India) Women?s Health Drugs Revenue in Global Market (2018-2023)
7.9.5 Lupin (India) Key News & Latest Developments
7.10 Eli Lilly And Company
7.10.1 Eli Lilly And Company Company Summary
7.10.2 Eli Lilly And Company Business Overview
7.10.3 Eli Lilly And Company Women?s Health Drugs Major Product Offerings
7.10.4 Eli Lilly And Company Women?s Health Drugs Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly And Company Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Women?s Health Drugs Major Product Offerings
7.11.4 Novartis AG Women?s Health Drugs Revenue in Global Market (2018-2023)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Summary
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Women?s Health Drugs Major Product Offerings
7.12.4 Johnson & Johnson Women?s Health Drugs Revenue in Global Market (2018-2023)
7.12.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Women?s Health Drugs Market Opportunities & Trends in Global Market
Table 2. Women?s Health Drugs Market Drivers in Global Market
Table 3. Women?s Health Drugs Market Restraints in Global Market
Table 4. Key Players of Women?s Health Drugs in Global Market
Table 5. Top Women?s Health Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Women?s Health Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Women?s Health Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Women?s Health Drugs Product Type
Table 9. List of Global Tier 1 Women?s Health Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Women?s Health Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Women?s Health Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Women?s Health Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Women?s Health Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Women?s Health Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Women?s Health Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Women?s Health Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Women?s Health Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Women?s Health Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Women?s Health Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Women?s Health Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Women?s Health Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Women?s Health Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Women?s Health Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Women?s Health Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Women?s Health Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Women?s Health Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Women?s Health Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Women?s Health Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Women?s Health Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Bayer AG Company Summary
Table 31. Bayer AG Women?s Health Drugs Product Offerings
Table 32. Bayer AG Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer AG Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Women?s Health Drugs Product Offerings
Table 36. Allergan Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. Merck & Co Company Summary
Table 39. Merck & Co Women?s Health Drugs Product Offerings
Table 40. Merck & Co Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck & Co Key News & Latest Developments
Table 42. Pfizer Inc Company Summary
Table 43. Pfizer Inc Women?s Health Drugs Product Offerings
Table 44. Pfizer Inc Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Inc Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Women?s Health Drugs Product Offerings
Table 48. Amgen Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Agile Therapeutics Inc Company Summary
Table 51. Agile Therapeutics Inc Women?s Health Drugs Product Offerings
Table 52. Agile Therapeutics Inc Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Agile Therapeutics Inc Key News & Latest Developments
Table 54. Ferring Pharmaceuticals Company Summary
Table 55. Ferring Pharmaceuticals Women?s Health Drugs Product Offerings
Table 56. Ferring Pharmaceuticals Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Ferring Pharmaceuticals Key News & Latest Developments
Table 58. Mylan N.V. Company Summary
Table 59. Mylan N.V. Women?s Health Drugs Product Offerings
Table 60. Mylan N.V. Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Mylan N.V. Key News & Latest Developments
Table 62. Lupin (India) Company Summary
Table 63. Lupin (India) Women?s Health Drugs Product Offerings
Table 64. Lupin (India) Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Lupin (India) Key News & Latest Developments
Table 66. Eli Lilly And Company Company Summary
Table 67. Eli Lilly And Company Women?s Health Drugs Product Offerings
Table 68. Eli Lilly And Company Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly And Company Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Women?s Health Drugs Product Offerings
Table 72. Novartis AG Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Novartis AG Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Women?s Health Drugs Product Offerings
Table 76. Johnson & Johnson Women?s Health Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
List of Figures
Figure 1. Women?s Health Drugs Segment by Type in 2022
Figure 2. Women?s Health Drugs Segment by Application in 2022
Figure 3. Global Women?s Health Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Women?s Health Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Women?s Health Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Women?s Health Drugs Revenue in 2022
Figure 8. By Type - Global Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Women?s Health Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Women?s Health Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 16. US Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 28. China Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Women?s Health Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Women?s Health Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Bayer AG Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck & Co Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Inc Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Agile Therapeutics Inc Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ferring Pharmaceuticals Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mylan N.V. Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lupin (India) Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly And Company Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Novartis AG Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Johnson & Johnson Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
